Welcome to our dedicated page for TransUnion SEC filings (Ticker: TRU), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The TransUnion (NYSE: TRU) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. These documents offer detailed information on TransUnion’s financial performance, governance and significant corporate events, complementing its role as a global information and insights company and major U.S. credit bureau.
Investors can review current reports on Form 8-K, where TransUnion reports material events such as quarterly earnings announcements and board changes. For example, the company has used 8-K filings to furnish press releases on results for specific quarters and to disclose the appointment of new directors and committee assignments. Such filings help readers understand how TransUnion’s leadership and reporting practices evolve over time.
In addition to 8-Ks, users typically look to annual reports on Form 10-K and quarterly reports on Form 10-Q for comprehensive discussions of business segments, risk factors, credit and fraud solution portfolios, and geographic footprint. These filings explain how TransUnion’s core credit bureau activities, fraud and identity solutions, marketing datasets and analytics offerings contribute to its overall business.
The Stock Titan platform enhances this information by providing AI-powered summaries that highlight key points from lengthy filings, helping readers navigate complex disclosures more efficiently. Real-time updates from the SEC’s EDGAR system ensure that new TransUnion filings appear promptly, while dedicated sections for insider transaction reports on Form 4 and proxy materials give additional insight into executive and director activity and governance matters.
Together, these resources allow investors, analysts and other stakeholders to examine TransUnion’s regulatory history, financial reporting and material events in a structured, accessible format.
TransUnion's Executive Vice President and Chief Operations Officer reported a planned sale of company stock. On 12/17/2025, the officer sold 4,318 shares of TransUnion common stock at $86 per share in an open-market transaction coded as a sale. The filing notes that the trades were executed under a pre-arranged Rule 10b5-1 trading plan, which is designed to allow insiders to sell shares according to a predetermined schedule. Following this transaction, the officer directly owns 50,427 shares of TransUnion common stock.
A holder of the issuer’s common stock filed a notice under Rule 144 to sell 4,318 shares through Fidelity Brokerage Services LLC. The planned sale has an aggregate market value of $371,348.00 and is expected around 12/17/2025 on the NYSE. According to the notice, 194,200,000 shares of the issuer’s common stock were outstanding. The securities to be sold were acquired as restricted stock that vested on 09/03/2025 as compensation from the issuer.
TransUnion's President, International reported a small planned stock sale. On 12/10/2025, the executive sold 500 shares of TransUnion common stock at $81.07 per share under a pre-arranged Rule 10b5-1 trading plan.
After this transaction, the officer directly beneficially owned about 32,652 shares of TransUnion common stock. The filing is a routine ownership report showing a modest disposition by a senior executive made pursuant to an established trading plan.
TransUnion has a shareholder planning to sell 500 shares of its common stock under Rule 144. The shares are to be sold through Fidelity Brokerage Services on the NYSE, with an aggregate market value of $40,535 at the time indicated in the notice. The shares were acquired on 02/25/2025 through restricted stock vesting as compensation from the issuer. The notice also reports that there are 194,200,000 common shares outstanding, which serves as a baseline for understanding the small size of this planned sale relative to the total equity.
TransUnion President, US Markets, reports small stock sale under 10b5-1 plan. A company officer sold 1,000 shares of TransUnion common stock on 12/01/2025 at a price of $84.04 per share in a transaction coded as a sale. The filing shows the officer beneficially owning 62,592 shares of TransUnion common stock after this transaction, held directly. The sale was carried out under a pre-established Rule 10b5-1 trading plan, which is intended to allow insiders to trade shares according to a set schedule or formula.
A shareholder of the issuer filed a notice to sell 1,000 shares of common stock through Fidelity Brokerage Services LLC on the NYSE, with an indicated aggregate market value of $84,040.00. The filing notes that there were 194,200,000 shares of this class outstanding at the time of the notice.
The 1,000 shares to be sold were originally acquired as restricted stock vesting from the issuer on 02/20/2022, treated as compensation. The same seller has sold additional common shares over the past three months: 1,000 shares on 09/02/2025 for gross proceeds of $86,120.00, 1,000 shares on 10/01/2025 for $83,190.00, and 1,000 shares on 11/03/2025 for $80,470.00.
TransUnion (TRU) reported an insider transaction: an officer serving as President, US Markets sold 1,000 shares of common stock on 11/03/2025 at $80.47 per share, coded “S.” The filing states the sale was made under a Rule 10b5-1 trading plan.
Following the transaction, the reporting person directly beneficially owns 63,592 shares. The filing is a single‑insider Form 4 and indicates direct ownership of the post‑transaction balance.
Massachusetts Financial Services Company filed an amended Schedule 13G/A disclosing a passive ownership stake in TransUnion (TRU) as of 09/30/2025. The firm reported beneficial ownership of 18,275,380 shares of common stock, representing 9.4% of the class.
MFS reported sole voting power over 17,789,790 shares and sole dispositive power over 18,275,380 shares, with no shared voting or dispositive power. The filer is classified as an investment adviser (IA) and certified the holdings were acquired and are held in the ordinary course, not for the purpose of changing or influencing control.
TransUnion (TRU) filed a Form 144 notice indicating a proposed sale of 1,000 shares of common stock through Fidelity Brokerage Services LLC, with an aggregate market value of $80,470. The filing lists an approximate sale date of November 3, 2025 on the NYSE.
The shares were acquired via restricted stock vesting from the issuer: 179 shares on February 20, 2022 and 821 shares on August 25, 2024, both noted as compensation. Over the past three months, Steven Chaouki reported sales of 1,000 shares on August 8, 2025 for $91,210, 1,000 shares on September 2, 2025 for $86,120, and 1,000 shares on October 1, 2025 for $83,190. The filing also notes 194,200,000 shares outstanding.
TransUnion reported Q3 2025 results. Revenue was $1,169.5 million, up from $1,085.0 million a year ago. Operating income was $207.6 million. Net income attributable to TransUnion was $96.6 million, or diluted EPS of $0.49.
U.S. Markets generated $912.8 million of gross revenue and International delivered $260.1 million. Year-to-date, cash provided by operating activities was $668.1 million, with capital expenditures of $229.3 million.
The Board authorized up to $1.0 billion for share repurchases; during Q3 the company repurchased about 1.26 million shares for $113.8 million. As of September 30, 2025, 194.2 million common shares were outstanding.
On April 1, 2025, TransUnion acquired the remaining 70% of Monevo for a total estimated purchase consideration of $115.7 million, recognizing $67.3 million of goodwill and $64.0 million of amortizable intangibles. Total debt was $5,120.1 million, and interest expense in Q3 was $62.5 million.
FAQ
What is the current stock price of TransUnion (TRU)?
What is the market cap of TransUnion (TRU)?
